Studies of the molecular pathogenesis of hexane neuropathy. I. Evaluation of the inhibition of glyceraldehyde‐3‐phosphate dehydrogenase by 2,5‐hexanedione

Informa UK Limited - Tập 6 Số 3 - Trang 621-631 - 1980
Doyle G. Graham1, Mohamed B. Abou‐Donia2
1Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710.
2Departments of Pathology and Pharmacology , Duke University Medical Center , Durham, North Carolina

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abou‐Donia M. B., 1977, Biophys. Chem., 6, 15, 10.1016/0301-4622(76)80057-9

Aldridge W. N., 1950, Biochem. J., 46, 451, 10.1042/bj0460451

Allen N., 1975, Arch. Neurol., 32, 209, 10.1001/archneur.1975.00490460025001

Chio K. S., 1969, Biochemistry, 8, 2821, 10.1021/bi00835a019

Forcina B. G., 1971, Eur. J. Biochem., 20, 535, 10.1111/j.1432-1033.1971.tb01424.x

Graham D. G., 1977, Cancer Res., 37, 436

Graham D. G., 1978, Mol. Pharmacol., 14, 644

Harris J. I., 1963, Nature (Lond.), 198, 154, 10.1038/198154a0

Katz G. V., 1980, Toxicol. Appl. Pharmacol., 52, 153, 10.1016/0041-008X(80)90254-9

Herskowitz A., 1971, N. Engl. J. Med., 285, 82, 10.1056/NEJM197107082850204

Main A. R., 1964, Science, 144, 992, 10.1126/science.144.3621.992

Main A. R., 1969, Can. Med. Assoc. J., 100, 161

Mendell J. R., 1974, Science, 35, 787, 10.1126/science.185.4153.787

Murdoch A. L., 1964, J. Biol. Chem., 239, 1983, 10.1016/S0021-9258(18)91294-9

Oski F. A., 1963, N. Engl. J. Med., 269, 763, 10.1056/NEJM196310102691501

Park J. H., 1961, J. Biol. Chem., 236, 136, 10.1016/S0021-9258(18)64441-2

Prineas J. B., 1969, J. Neuropathol. Exp. Neurol., 28, 598, 10.1097/00005072-196910000-00004

Sabri M. I., 1979, Neurotoxicology, 1, 285

Sabri M. I., 1979, J. Neurochem., 32, 683, 10.1111/j.1471-4159.1979.tb04550.x

Schaumburg H. H., 1976, Brain, 99, 183, 10.1093/brain/99.2.183

Schaumburg H. H., 1974, J. Neuropathol. Exp. Neurol., 33, 260, 10.1097/00005072-197404000-00006

Spencer P. S., 1975, J. Neurol. Neurosurg. Psychiatry, 8, 771, 10.1136/jnnp.38.8.771

Spencer P. S., 1976, Toxicol. Appl. Pharmacol., 37, 301, 10.1016/0041-008X(76)90093-4

Spencer P. S., 1977, J. Neuropathol. Exp. Neurol., 36, 276, 10.1097/00005072-197703000-00005

Spencer P. S., 1977, J. Neuropathol. Exp. Neurol., 36, 300, 10.1097/00005072-197703000-00006

Spencer P. S., 1978, Physiology and Pathobiology of Axons, 265

Spencer P. S., 1975, Arch. Neurol., 32, 219, 10.1001/archneur.1975.00490460035002

Spencer P. S., 1978, Toxicol. Appl. Pharmacol., 44, 17, 10.1016/0041-008X(78)90280-6

Spencer P. S., 1979, Ann. Neurol., 5, 501, 10.1002/ana.410050602

Szendzikowski S., 1974, Structure and Function of Normal and Diseased Muscle and Peripheral Nerve, 319

Towfighi J., 1976, Neurology, 26, 238, 10.1212/WNL.26.3.238

Webb, J. L. 1963.Enzyme and Metabolic Inhibitors, vol. 1, 535–603. New York: Academic.